Docebo (DCBO)
(Delayed Data from NSDQ)
$45.21 USD
+1.73 (3.98%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $45.22 +0.01 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value A Growth D Momentum C VGM
Income Statements
Fiscal Year end for Docebo Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 181 | 143 | 104 | 63 | NA |
Cost Of Goods | 35 | 28 | 21 | 12 | NA |
Gross Profit | 146 | 115 | 83 | 51 | NA |
Selling & Adminstrative & Depr. & Amort Expenses | 150 | 111 | 97 | 59 | 0 |
Income After Depreciation & Amortization | -4 | 4 | -13 | -8 | 0 |
Non-Operating Income | 0 | 0 | 0 | 0 | NA |
Interest Expense | -9 | -4 | 0 | 0 | NA |
Pretax Income | 5 | 8 | -13 | -8 | NA |
Income Taxes | 2 | 1 | 0 | 0 | NA |
Minority Interest | 0 | 0 | 0 | 0 | NA |
Investment Gains/Losses | 0 | 0 | 0 | 0 | NA |
Other Income/Charges | 0 | 0 | 0 | 0 | NA |
Income From Cont. Operations | 3 | 7 | -14 | -8 | NA |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | NA |
Net Income (GAAP) | 3 | 7 | -14 | -8 | NA |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -1 | 7 | -11 | -6 | 0 |
Depreciation & Amortization (Cash Flow) | 3 | 2 | 2 | 1 | NA |
Income After Depreciation & Amortization | -4 | 4 | -13 | -8 | 0 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 33.68 | 34.04 | 32.87 | 28.94 | NA |
Diluted EPS Before Non-Recurring Items | 0.45 | -0.07 | -0.41 | -0.26 | NA |
Diluted Net EPS (GAAP) | 0.08 | 0.21 | -0.41 | -0.26 | NA |
Fiscal Year end for Docebo Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | 53.05 | 51.40 | 49.28 | 46.51 | 43.59 |
Cost Of Goods | 10.26 | 9.93 | 9.26 | 8.78 | 8.41 |
Gross Profit | 42.80 | 41.48 | 40.03 | 37.73 | 35.18 |
SG&A, R&D, and Dept/Amort Expenses | 38.27 | 37.25 | 38.94 | 34.62 | 42.70 |
Income After SG&A, R&D, and Dept/Amort Expenses | 4.53 | 4.23 | 1.09 | 3.11 | -7.52 |
Non-Operating Income | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | -0.67 | -0.55 | -2.23 | -1.93 | -2.41 |
Pretax Income | 5.21 | 4.77 | 3.31 | 5.04 | -5.12 |
Income Taxes | 0.51 | -0.40 | 0.09 | 1.00 | 0.56 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 4.70 | 5.17 | 3.22 | 4.05 | -5.67 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 4.70 | 5.17 | 3.22 | 4.05 | -5.67 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | 31.06 | 31.04 | 32.86 | 33.51 | 33.15 |
Diluted EPS Before Non-Recurring Items | 0.19 | 0.18 | 0.21 | 0.09 | 0.10 |
Diluted Net EPS (GAAP) | 0.15 | 0.17 | 0.09 | 0.12 | -0.17 |